Search

everythinglearnresearchcommunity

for

Search:↓

Rosacea may be linked to gut and brain issues, not just a skin problem.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Extracellular vesicles can help regenerate bones but need more research for safe clinical use.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

Stem cells have great potential for treating various medical conditions.

Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.

Botulinum toxin can safely and effectively treat facial wrinkles and muscle issues with precise injection techniques.

DLP bioprinting shows promise for medical uses, but needs more material options and strength improvements.

Triboelectric nanogenerators can power wearable medical devices for long-term self-treatment and monitoring.

Piezoelectric Nanogenerators are promising for non-invasive health monitoring but need efficiency and durability improvements.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Silk fibroin shows promise for wound care but faces challenges in becoming widely available.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Long COVID is a complex condition with many symptoms and unknowns, needing more research.

Peptide-based hydrogels are promising for healing chronic wounds effectively.

Platelet-rich concentrates can be an alternative treatment for oral lichen planus, especially when steroids don't work.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Caffeine may help with hair loss, but more research is needed.